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Background: Environmental and genetic factors contribute to variation in irritable bowel syndrome (IBS), anxiety
and depression. Comorbidity between these disorders is high. A previous investigation of our population-based
twin cohort revealed that low birth weight increased the risk for development of IBS, with environmental influences
in utero as the most relevant contributing factor. We hypothesise that both intrauterine and genetic factors influence
the co-occurrence of IBS and symptoms of anxiety and depression.
Methods: A postal questionnaire sent to 12700 Norwegian twins born between 1967 and 1979 comprised a checklist of
31 illnesses and symptoms, including IBS and symptoms of anxiety and depression. The influence of genetic factors and
intrauterine growth on comorbidity between these disorders were analysed in the full sample and compared to those
based on only monozygotic (MZ) twin pairs discordant for IBS (95 pairs) in birth weight group < 2500 g and≥ 2500 g.
Results: In the co-twin analyses restricted growth (birth weight < 2500 g) was significantly associated with anxiety and
depression (average birth weight difference of 181.0 g (p <0.0001) and 249.9 g (p < 0.0001), respectively).
The analysis of the full sample revealed that IBS was significantly associated with symptoms of anxiety (adjusted OR = 2.5,
95% CI: 1.9, 3.3) and depression (adjusted OR = 2.3. 95% CI: 1.8, 3.0). Analyses of MZ pairs discordant for IBS indicated
significant associations between IBS and symptoms of anxiety (OR = 3.7, 95% CI: 1.3, 10.5) and between IBS and
symptoms of depression (OR = 4.2, 95% CI: 1.7, 9.9) only in the birth weight group below 2500 g.
Conclusion: Our findings suggest that genetic factors partly explain the association between IBS and symptoms of
anxiety and depression. In the low range of birth weight (<2500 g), restricted fetal growth seems to be a common
contributing factor to the co-occurrence between these disorders.
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Irritable bowel syndrome (IBS) is characterized by ab-
dominal pain and abnormal bowel pattern affecting ap-
proximately 10–20% of the general population [1,2]. The
pathogenesis remains unclear, but accepted mechanisms
involve an interaction between triggering environ-
mental factors and abnormal gastrointestinal motility
and disturbed visceral sensory perception [3-7]. Gene-
environmental interactions are also important in the* Correspondence: maybente.bengtson@gmail.com
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patients [7-10].
Multiple investigations conducted during the past two
decades implicate genetic factors in the development of
IBS. Family studies reveal that the frequency of self-
reported IBS was significantly greater among those who
reported having a first-degree relative with bowel prob-
lems than among those whose spouse had IBS [9]. Re-
sults from our population-based Norwegian twin study
[8] concur with twin-based findings from other countries
[10,11] and highlight the importance of genetic influ-
ences on IBS with significantly greater concordance rates
among monozygotic (MZ) compared to dizygotic (DZ)
pairs. Our earlier twin study [8] also demonstrated anral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and development of IBS later in life; moreover, birth
weight below 1500 g was associated with early onset of
symptoms.
IBS patients report more frequent emotional distress
and depression than controls, and IBS symptoms are
often exacerbated during periods of stressful events [12].
Furthermore, anxiety and depression contribute to poor
outcomes in IBS [13,14]. Numerous investigations have
reported comorbidity between IBS and stress-related
psychiatric disorders as high as 30–50% [14-18]. However,
studies of the causal relation between these disorders are
sparse and provide contradictory results [19-21].
In the present study we hypothesise that restricted
intrauterine growth and familial factors influence the co-
occurrence of IBS and mental distress. Familial factors
comprise genetic factors and/or early familial influ-
ences associated with being raised as twins in the same
household.
We used a case–control and co-twin control design in
combination to assess whether co-morbidity between
IBS and the mental health outcomes is due to within
pair familial factors shared by the twins or due to a
causal link between them. Furthermore, we expanded
this test of the sources of comorbidity to explore the influ-
ence of restricted fetal growth by stratifying the co-twin
control study into two birth weight groups, < 2500 g
and ≥ 2500 g.
Methods
The data are based on a population-based sample of
twins [22,23] identified from the Norwegian national
birth registry, which was established in 1967. Postal
questionnaires were sent in 1998 to 12700 twins born
between 1967 and 1979.
The final sample included 8045 twins (63% response
rate), 3334 twin pairs and 1377 single responders. Of
3334 twin pairs, 138 pairs were excluded due to incom-
plete data. The final sample included 504 male monozy-
gotic (MZM), 379 male dizygotic (DZM), 746 female
monozygotic (MZF), 635 female dizygotic (DZF), and
932 dizygotic unlike pairs (DZU). Among these, there
were 321 twin pairs for which at least one of the twins
reported a positive history of IBS.
Initial screening for potential cases was conducted
using self-reported questionnaire responses. The ques-
tionnaire included a checklist for 31 illnesses and symp-
toms, including IBS. The question was phrased as: Do
you have, or have you ever had irritable bowel syndrome
(diarrhoea, constipation, and painful abdominal disten-
sion). Two other questions on gastrointestinal diseases
were asked: one question inquired about symptoms con-
sistent with dyspepsia, where we used the phrase; recur-
rent upper abdominal pain, and another concerninginflammatory bowel disease (IBD), where we used the
terms Crohn’s disease and ulcerative colitis. A diagnosis
of IBD was confirmed through the patient’s doctor. Age
at onset was asked, and if symptoms were not currently
present, the subject was asked to record the time of the
last event. Age at onset and cessation of symptoms were
coded as continuous variables. Thirteen twins checked
the box for both IBS and IBD. Seven of these responded
to an invitation for a study of IBD, and consented to a
phone interview. Four of these patients appeared to have
IBS, and not IBD, and three had IBD, which was con-
firmed by journal records. The twins with IBD (three
twins) and the none-responders (six twins) were ex-
cluded, which resulted in data from 312 twin pairs avail-
able for the analyses.
Items pertaining to sleep disorder and somatic disor-
ders, such as frequent headache, long-lasting muscle
pain and diabetes were also included in the questionnaire.
Symptoms of anxiety and depression were assessed using
five questions from the Symptom Check List (SCL-5) anx-
iety and depression subscales that were also included in
the questionnaire. This short version has been shown to
correlate 0.92 with the full scale score list of Hopkin’s
(HSCL-25) anxiety and depression score [24], 10 items for
anxiety and 15 items for depression.
The short form version included two items of anxiety;
1) feeling fearful, 2) nervousness or shakiness inside, and
3 items of depression; 1) feeling hopeless about the fu-
ture, 2) feeling blue, 3) worrying too much about things.
The participants were asked to classify the symptoms ac-
cording to a four-point scale with anchors 1 (Not at all)
to 4 (Extremely).
Values for the symptoms of anxiety and depression
were calculated by summing the scores for each item be-
longing to the respective subscale and computing mean
values. Mean values ≥ 2 were used as cut of points for
symptoms of anxiety and depression [25].
Marital status included; 1) unmarried/not live-in
partner, 2) married/live-in partner, 3) widow/widower,
4) divorced/separated. Educational level was split in
two variables; completed and planned education, because
the participants were aged between 19 and 31 years. The
education level included: 1) high school or secondary
school plus two or three years additional training or
economic education, 2) college or university up to 4 years,
3) master degree or PhD.
Data on birth weight and gestational age were ob-
tained from the Medical Birth Registry of Norway. Clas-
sification of zygosity was based on responses to seven
questionnaire items, which have been verified in a previ-
ous study of Norwegian twins to correctly categorize zy-
gosity with 97% accuracy [22]. These classifications were
further verified through an update of The Norwegian
Institute of Public Health twin program of research
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genotyped on 676 of the like-sex pairs in the sample. Re-
sults from these markers were used as dependent vari-
ables in a discriminant analysis with the questionnaire
items as independent variables. Seventeen of these pairs
(2.5%) were misclassified by the questionnaire data and
zygosity classifications were corrected. From these data,
we estimated that, in our entire sample, zygosity mis-
classification occurred in 1% of pairs, a rate unlikely to
substantially bias results.
Analyses
Probandwise concordance was calculated by zygosity for
anxiety and depression. This concordance rate is defined
as the ratio of twice the number of concordant pairs, di-
vided by twice the number of concordant pairs plus the
number of discordant pairs. Differences in concord-
ance rates between MZ and DZ pairs were tested using
χ2 statistics.
To indicate the level of comorbidity between depres-
sion and anxiety, the ĸ statistics were measured, and re-
ported with 95% confidence interval (CI). A value of 1.00
indicate perfect agreement, whereas 0.00 only agreement
by chance.
Paired-t tests were used to analyse the associations be-
tween LBW with symptoms of anxiety and depression.
To control for genetic factors, which may contribute to
low birth weight as well as to anxiety and depression,
two separate analyses were conducted using only data
from MZ pairs discordant for anxiety or depression, re-
spectively. The data were stratified into two groups accord-
ing to the birth weight of the affected twin, ≥ 2500 g
or < 2500 g, and differences in mean birth weight be-
tween twins with and without symptoms of anxiety
or depression were estimated. To increase statistical
power, the birth weight group < 2500 g included pairs
where both twins were below 2500 g and twin pairs where
only the affected twin had a birth weight below 2500 g.
Separate logistic regression models were fitted for anxiety
and depression to analyse potential confounding effects of
marital status and education. Birth weight, split into quar-
tiles, was included in these models.
To explore if age at onset of symptoms of IBS was a
risk factor for the association between IBS and depres-
sion or anxiety, the data from twins with IBS were strati-
fied into two groups, representing those older and
younger than 15 years at age of IBS onset. Age at survey
was grouped into four categories each representing
3-year intervals.
Co-occurrence of IBS with symptoms of anxiety
or depression
Logistic regression models were used to analyse the
co-occurrence of IBS with symptoms of anxiety anddepression. Separate models were analysed for the associ-
ation between IBS with each mental health outcome. Odds
ratios (OR) with 95% confidence intervals (CI) were calcu-
lated adjusted for gender, age at the time of survey and
twin relatedness (GEE), using SPSS 20 in the full twin
sample. ORs in the co-twin control analyses were esti-
mated using logistic regression with twin pairs as the unit
of analysis.
To assess possible effect measure modification, interac-
tions between anxiety and gender and between gender and
depression were included in the model. Interaction terms
which were significant for the associations IBS-anxiety or
IBS-depression, were included in the models because risk
of anxiety and depression could be different for the men
and women belonging to the same age groups.
The associations between IBS and symptoms of anx-
iety or depression were first tested in the full twin sam-
ple (case–control design), and further analysed using
only data from IBS-discordant MZ twins (co-twin con-
trol design). Adjusting for twin relatedness in the ana-
lyses in the full twin sample supports generalisation to
the background population.
This methodology was described previously by
Wojczynski et al. [21], and is based on the assumption
that resemblance between MZ twins, who are genetically
identical, may also stem from shared early environmental
factors important for the disorder of interest such as par-
ental rearing, childhood trauma, same housing, pets,
similar diet and same infectious diseases, etc.
Therefore, if an association is found in the case–
control design study but not in the co-twin control design,
this indicates that the comorbidity depends partly on gen-
etic and/or family environment influences. However, if an
association is found between IBS and the mental health
measures in both the case–control and the co-twin control
design, this would suggest a causal link between these
health outcomes [21].
We expanded this test of the sources of comorbidity
to explore the influence of restricted fetal growth by
stratifying the co-twin control study into two birth
weight groups, < 2500 g and ≥ 2500 g. If an association
of IBS with the mental health outcomes is demonstrated
only in the lowest birth weight group this would suggest
that comorbidity arises from a causal biological mechan-
ism due to restricted fetal growth.
Ethical approval
This study was evaluated and approved by the Norwegian
Scientific Ethics Committees and by the Norwegian Data
Protection Agency. Our ethics review approved that the re-
turn of the questionnaire by the twins, meant that they
consented. In the invitation letter, dispatched with the
questionnaire, we explained how the data would be used
and that the study was voluntary.
Table 2 Concordance rates and probandwise concordance
rates for irritable bowel syndrome (IBS), depression and
anxiety among monozygotic (MZ) and dizygotic (DZ) twins
MZ DZ Total no
pairs
IBS Concordant pairs 14 10 24
Discordant pairs 95 193 288
Probandwise concordance rate 0.23 0.09*
Depression Concordant pairs 67 82 149
Discordant pairs 232 455 687
Probandwise concordance rate 0.22 0.15*
Anxiety Concordant pairs 56 55 111
Discordant pairs 186 422 608
Probandwise concordance rate 0.23 0.12*
*Significant higher concordance rate among MZ compared to DZ twins.
Table 3 Somatic – psychiatric comorbidity among
irritable bowel syndrome (IBS) cases and controls
IBS case–control population (N = 6374)
Cases N (%) Controls N (%) OR (95% CI)
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The lifetime prevalence of IBS in this twin cohort has
been previously reported to be 5.3%, with a female pre-
dominance of 76.5%. Furthermore, the majority of cases
(75.5%) reported ongoing IBS symptoms at the time of
survey [8]. The present study revealed that 13 and 15.5%
of the twins reported ongoing symptoms of anxiety and
depression, respectively. Females accounted for the ma-
jority of those reporting symptoms of anxiety (73.5%)
and depression (68.3%).
The number of twin pairs and cases by zygosity are
listed in Table 1 for each health condition. The concord-
ance rates are presented in Table 2. Concordance was
significantly greater among MZ than DZ pairs for symp-
toms of anxiety (p = 0.03), symptoms of depression
(p < 0.0001) and IBS (p = 0.011).
Somatic comorbidity including factors such as sleep
disorder, frequent headache, long-lasting muscles pain
and dyspepsia were more common among cases of IBS
(Table 3) and among those reporting symptoms of anx-
iety and depression (Table 4), compared to controls.
There was a high level of comorbidity between symp-
toms of anxiety and depression (κ = 0.49, 95% CI: 0.45,
0.52) (Table 4). Age at onset of IBS symptoms did not
influence the associations between IBS and symptoms
of anxiety (OR = 1.2, 95% CI: 0.6, 2.5) or depression
(OR = 1.2, 95% CI: 0.6, 2.1).
Effect of birth weight using a co-twin design approach
Among the MZ twins, 186 pairs were discordant for the
measure of anxiety and 232 pairs were discordant for
the measure of depression. In these pairs, low birth
weight (below 2500 g) occurred for 77/186 of the anxiety
discordant pairs and 100/232 of the depression discord-
ant pairs. The affected twins in the low birth weight
group weighed significantly less at birth compared to
their unaffected co-twins with average birth weight dif-
ferences of 181.03 g (p <0.0001) for symptoms of anxiety
and 249.95 g (p < 0.0001) for symptoms of depression.
Twins with and without anxiety and depression in the
low birth weight group, did not differ regarding complete
or planned education status. The risk of depression, but
not anxiety, was significantly lower for married compared
to unmarried participants (OR = 0.4, 95% CI: 0.2, 0.8 and
OR = 0.8, 95% CI: 0.4, 1.6, respectively). The odds forTable 1 Number of twin pairs and cases for each disorder
by zygosity in a Norwegian population-based cohort
Groups Pairs Cases of irritable
bowel syndrome
Cases of
depression
Cases of
anxiety
Monozygotic 1250 123 336 298
Dizygotic 1946 213 619 532
Total 3196 336 985 830depression, adjusted for marital status, was 2.7 times higher
(95% CI: 1.2, 5.9) for those in the lower quartile group of
birth weight compared to those in the upper quartile
group.
Case–control model
Of the 336 twins who reported IBS, 95 (28.3%) and 102
(30.4%) also reported symptoms of anxiety and depres-
sion, respectively. The case–control analyses revealed a
significant association between IBS and symptoms of
anxiety and between IBS and symptoms of depression
(crude OR = 2.8, 95% CI: 2.2, 3.7, and crude OR = 2.5.
95% CI: 1.9, 3.3, respectively). Female gender, but not
age at survey, appeared to be an independent risk factor
for IBS in the models. The associations between IBS and
symptoms of anxiety or depression were slightly attenu-
ated when adjusted for gender (OR = 2.5, 95% CI: 1.9,
3.3, and OR = 2.3, 95% CI: 1.8, 3.0, respectively).
Comorbid sleeping disorder was significantly higher
among IBS cases with symptoms of anxiety and depres-
sion compared to IBS cases without these disorders(N = 336) (N = 6038)
Female 258 (76.8) 3423 (56.7) 2.5 (1.9, 3.3)
Sleep disorder 87 (25.9) 420 (7) 4.7 (3.6, 6.1)
Frequent headache 87 (25.9) 626 (10.4) 3.0 (2.3, 3.9)
Long-lasting muscles pain 48 (14.3) 219 (3.6) 4.4 (3.2, 6.2)
Dyspepsia 69 (20.5) 175 (2.9) 8.7 (6.4, 11.7)
Depression 102 (30.4) 569 (9.4) 2.8 (2.2, 3.7)
Anxiety 95 (28.3) 333 (5.5) 3.1 (2.3, 4.3)
Table 4 Somatic comorbidity among twins with depression and anxiety in the Norwegian twin registry
Case–control population (N = 6374)
Depression Anxiety
Cases N (%) Controls N (%) OR (95% CI) Cases N (%) Controls N (%) OR (95% CI)
N = 985 N = 5389 N = 830 N = 5544
Female 673 (68.3) 3008 (55.8) 1.7 (1.5, 1.9) 610 (73.5) 3071 (55.4) 2.2 (1.9, 2.6)
Sleep disorder 220 (22.3) 287 (5.3) 5.1 (4.2, 6.2) 205 (24.7) 302 (5.4) 5.7 (4.7, 6.9)
Frequent headache 179 (18.2) 534 (9.9) 2.0 (1.7, 2.4) 176 (21.2) 537 (9.7) 2.5 (2.1, 3.0)
Long-lasting muscles pain 82 (8.3) 185 (3.4) 2.5 (1.9, 3.3) 83 (8.9) 184 (3.3) 3.2 (2.5, 4.2)
Dyspepsia 71 (7.2) 173 (3.2) 2.2 (1.8, 3.1) 74 (8.9) 170 (3.1) 3.1 (2.3, 4.1)
Diabetes 10 (1) 38(0.7) 1.4 (0.7, 2.9) 10 (1.2) 38 (0.7) 1.8 (0.9, 3.6)
Irritable bowel syndrome 77(11.9) 259 (4.5) 2.8 (2.1, 3.7) 95 (11.4) 2841(4.3) 2.8 (2.2, 3.7)
Depression 510 (61.4) 475 (8.6) 17.0 (14.3, 20.1)
Anxiety 510 (51.8) 320 (5.9) 17.0 (14.3, 20.1)
Figure 1 Symptoms of anxiety among MZ twins discordant for
IBS. The assoiation between IBS and symptoms of anxiety among
MZ twins was demonstrated only in the birth weight groups < 2500 g,
indicating restricted fetal growth as a common contributing factor in
the low range of birth weight.
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40.2%, OR = 2.0, 95% CI: 1.4, 2.9). Cases of IBS with
anxiety (20/95, 21.1%, OR = 1.8, 95% CI: 1.1, 3.1) were
more likely to have comorbid long-lasting muscle pain,
but depression did not reach significance (20/102, 19.6%,
OR = 1.6, 95% CI: 0.9, 2.8). Comorbid frequent headache
did not show a similar trend.
Co-twin control analyses: MZ twins discordant for IBS
The analyses of data from MZ twins discordant for IBS
(95 pairs) revealed that the risk of comorbid symptoms
of anxiety (24/95, 25.3%) (OR = 2.2, 95% CI: 1.1, 4.2) and
depression (28/95, 29.5%) (OR = 1.9, 95% CI: 0.9, 3.7)
was higher among twins with IBS compared to those
without IBS, but did not reach significance for de-
pression (p = 0.055). Sleeping disorder (24/95, 25.3%)
(OR = 2.9, 95% CI: 1.3, 6.4) and long-lasting muscle
pain (16/95, 16.8%) (OR = 9.4, 95% CI: 2.1, 42.2) were
significantly associated with IBS, but frequent headache
was not associated with IBS (27/95, 28.4%) (OR = 1.5,
95% CI: 0.8, 2.9).
Co-twin control analyses: MZ twins discordant for IBS by
birth weight group
Data from MZ twin pairs discordant for IBS were
stratified into birth weight groups defined as < 2500 g
or ≥ 2500 g. Significant associations were found be-
tween IBS and symptoms of anxiety (16/41, 39.0%)
(OR =3.7, 95% CI: 1.3, 10.5) (Figure 1), and between IBS
and symptoms of depression (17/41, 41.5%) (OR = 4.2,
95% CI: 1.7, 9.9) in the weight group < 2500 g (41 pairs)
(Figure 2). Among the twins within normal range of birth
weight, ≥ 2500 g (54 pairs), there was no association
between IBS and symptoms of anxiety (8/54, 14.8%)
(OR = 1.2, 95% CI: 0.4, 3.5) or between IBS and symptoms
of depression (11/54, 20.4%) (OR = 1.0, 95% CI: 0.4, 3.5).The risk for comorbid symptoms of anxiety (OR = 2.6, 95%
CI: 1.3, 5.6) and depression (OR = 2.0, 95% CI: 1.1, 3.9)
among twins with IBS weighing less than 2500 g at
birth was twice as high compared to those with IBS and
weighing ≥ 2500 g.
Discussion
This study demonstrated that both familial and intra-
uterine factors influence the co-occurrence of IBS and
symptoms of anxiety and depression in a Norwegian
population-based twin cohort. To examine the nature of
the comorbidity between these disorders, associations
between IBS and symptoms of anxiety and depression
were first tested in the full twin sample (case–control),
and then further analysed using data from MZ twin pairs
discordant for IBS. The results from these analyses were
compared to help elucidate the importance of familial
Figure 2 Symptoms of depression among MZ twins discordant
for IBS. The association between IBS and symptoms of depression
was demonstrated only in the birth weight group < 2500 g, indicating
restricted fetal growth as a common contributing factor in the low
range of birth weight.
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the comorbidity of these disorders. Further analyses
using only discordant MZ twin pairs (co-twin control
design) stratified into two birth weight groups, < 2500 g
and ≥ 2500 g explored the significance of intrauterine
conditions as a common risk factor for comorbidity of
IBS with the mental health outcomes. Our analyses con-
firmed associations between IBS and symptoms of anx-
iety and depression (OR = 2.5, 95% CI: 1.9, 3.3, OR = 2.3,
95% CI: 1.8, 3.0, respectively) in the case–control study
as well as in the co-twin design study. These findings are
in agreement with the results of Wojczynski et al., who
introduced this novel twin study design in a population-
based Swedish twin cohort [21]. They consequently con-
cluded that comorbidity between IBS and depression
could not be explained by genetic or family environmen-
tal factor, but rather by a possible causal link between
these disorders.
However, in the present study, we were able to dem-
onstrate that both genetic and environmental mecha-
nisms contribute to the comorbidity between mental
disorders and IBS, by stratifying the co-twin control study
into two birth weight groups, < 2500 g and ≥ 2500 g.
Our analyses revealed significant comorbidity between
IBS and symptoms of anxiety and depression only in the
birth weight group < 2500 g (OR =3.7, 95% CI: 1.3, 10.5,
OR = 4.2, 95% CI: 1.7, 9.9, respectively). In normal range
of birth weight (≥2500 g), we did not find any associ-
ation between IBS and mental health conditions, in
contrast to the case–control findings, indicating that co-
morbidity of IBS with symptoms of anxiety and depres-
sion could partly be explained by genetic or family
environment influence. Furthermore, results from these
analyses help to disentangle effects due to restricted fetalgrowth as a significant common contributor to the co-
occurrence of these disorders in the low range of birth
weight scale (<2500 g).
Genetic modelling based on this twin cohort have earl-
ier demonstrated that shared family environment did
not contribute to development of either IBS or symp-
toms of anxiety and depression [8,26], suggesting that
genetic factors account for the main source of resem-
blance between MZ twins when it comes to these
disorders.
The influence of restricted birth weight for develop-
ment of mental health conditions was confirmed by the
paired t-tests in the birth weight group < 2500 g. These
analyses yielded a significant weight difference of 181.0 g
(p < 0.0001) and 249.9 g (p < 0.0001) favouring the twin
without symptoms of anxiety and depression, respect-
ively. Marital status and education level did not modify
the association between these disorders and restricted
intrauterine growth. Lower birth weight in affected
twins, meaning restricted growth, indicates that environ-
mental factor during fetal life play an important role for
development of symptoms of anxiety and depression
later in life. These results are in line with other investi-
gations revealing that low birth weight (LBW), defined
as birth weight < 2500 g, increases the risk for behav-
ioural, emotional, and learning difficulties as well as
poor cognitive function in school-age children [27-29].
The link between LBW and development of mental
health conditions later in life might be explained by
long-term dysfunction of the Hypothalamic-Pituitary-
Adrenal (HPA) -axis induced in fetal life by program-
ming. Fetal programming is a process whereby a stimu-
lus or an insult in a critical period during fetal life
results in permanent change of structure or physi-
ology of the organism [30]. Both physical and psy-
chological stressors contribute to hypothalamic release of
corticotropin-releasing factor (CRF) [31,32], which stim-
ulates release of the stress hormones adrenocorticotropin
hormone (ACTH) from the pituitary and cortisol from
the adrenal glands. Measurements of basal cortisol and
ACTH, as well as stimulated cortisol and ACTH are the
most common approach to evaluate the function of the
HPA-axis [33]. Exposure to intrauterine stress, measured
by LBW, may increase the vulnerability to subsequent
normative stress later in life by changing the function of
the HPA-axis [34].
Changed basal levels of cortisol [35] and ACTH have
also been demonstrated among patients with IBS. Dys-
functional HPA-axis involves the pathogenesis of IBS by
contributing to visceral hypersensitivity [5] and altered
bowel motility [6]. The association between restricted
birth weight and symptoms of anxiety or depression in
the present study, and between IBS and restricted birth
weight showed in our previous study [8], might suggest
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these disorders, in the LBW group. Moreover, the co-
morbidity between IBS and symptoms of anxiety or
depression was confirmed only in the LBW group, sug-
gesting that the same mechanism contributes to the oc-
currence between these disorders.
The analyses in the full sample of twins revealed sig-
nificant associations between IBS and somatic disorders
like sleeping disorder, frequent headache and long-
lasting muscle pain. Furthermore, IBS cases with symp-
toms of anxiety and depression had an even higher risk
for comorbid sleeping disorder and long-lasting muscle
pain compared to IBS case without these comorbid dis-
orders, in line with the results in the investigation of
Lembo et al. [19]. In the co-twin design study similar as-
sociations were found between IBS and sleeping disorder
and long-lasting muscle pain, indicating that these som-
atic disorders share common biological pathway as IBS.
Sleeping disorder and long-lasting muscle pain, have
been linked to hypervigilance to bodily symptoms, and
closely associated with IBS [36]. Several twin and fam-
ily investigations revealed that genetic factors contrib-
ute to the development of IBS [9,10] and account for
a substantial part the variability of psychiatric disor-
ders [37,38]. Furthermore, studies have demonstrated
shared genetic factors between depression and anxiety
disorder [39].
The concordance rate among MZ twins for anxiety
(p = 0.03) and depression (p < 0.0001) in the present
study, and for IBS (p = 0.011) demonstrated in the
same twin cohort previously were significantly higher
than among DZ twins [8]. Moreover, there was a large
overlap between symptoms of anxiety and depression, with
a kappa value of 0.49 (p <0.0001).
Recent investigations have shown that IBS and mental
disorder share common genetic pathways like the se-
rotonergic pathway and the corticotrophin releasing
system [40].
We demonstrated comorbid symptoms of anxiety and
depression among approximately 30% of the twins
reporting symptoms of IBS in the full sample, and al-
most similar associations among MZ twins discordant
for IBS. Furthermore, the risk of comorbid symptoms of
anxiety (39.0%) and depression (41.5%) was twice as high
in the birth weight group < 2500 g compared to the
group ≥ 2500 g, suggesting a differentiation in the patho-
genesis of sub-groups of IBS according to birth weight
groups.
The estimated lifetime prevalence of IBS the study of
Wojczynski et al. (2.06%) [21] was less than half the
prevalence of IBS in the present study (5.3%), and prob-
ably reflects the difference of IBS definitions used in the
studies. Wojczynski et al. explained that their use of an
adapted version of the Rome criteria probably includedmostly diarrhoea-predominant IBS, which usually repre-
sents less than a third of an IBS population [14].
The notably lower prevalence of IBS (2.06%), in con-
junction with a higher lifetime prevalence of depression
(21.5%) reported in the study of Wojczynski might par-
tially explain why comorbidity between depression and
IBS was much higher (45%), than we report (30.4%). The
prevalence of IBS in our twin cohort (5.3%) is lower
compared to the prevalence found in a population-based
study in Norway from general practice (8.4%), which in-
cluded approximately 11 000 inhabitants aged between
30 to 75 years [14]. The questionnaire used to determine
IBS symptoms in that study [14] was based on the Rome
II criteria in contrast to our study. The twins in our
study seem to be familiar with the term irritable bowel
syndrome, possibly as a result of medically based diagno-
sis, and responded to the symptoms, constipation, diar-
rhoea and painful abdominal distension, which all are
important components of IBS. Furthermore, the typical
chronic course of intermittent symptoms of IBS has
been demonstrated earlier in the same twin sample as
the present study [8].
In spite of lower lifetime prevalence of IBS in the
Norwegian twin cohort compared to the study in
general practice [14], both investigations demonstrated a
3- to 5-fold increased risk of comorbid disorders like
depression, anxiety, skeletal and pain related disorder
(Table 3). And even more important, Vandvik et al. [14]
showed a prevalence of comorbid mood disorder of 25%
among IBS consulters as well as IBS non-consulters. If
the IBS diagnosis in the present study was mainly re-
stricted to IBS consulters, comorbidity of symptoms of
anxiety and depression is comparable with the findings in
the background population.
Vanvik et al. [14] measured anxiety and depression
symptom with the Hopkins’ Symptoms Checklist-10
with cut-off point of ≥ 1.85, while the present study in-
cluded 5 instead of 10 symptoms in the list for anxiety
and depression (Hopkins’ Symptoms Checklist-5) with
cut-off point ≥2, in line with the recommendation as
valid predictor of mood disorder [25].
Only gender (male), which questionnaire was received
first, and low birth weight were associated with de-
creased possibility of participating in our study. Re-
sponses to the questionnaire were received from a
larger percentage of females (70%) than males (56%),
which might part explain the predominance of IBS
among females (7.0%) compared to males (2.9%). The
difference in birth weight between our twin cohort and
non-responders was 29 g (95% CI: 9.3, 49.4, p = 0.004)
and could lead to a slightly underestimation of odds for
IBS as well as anxiety and depression, and therefore
unlikely to influence the comorbidity between these
disorders.
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The present twin study revealed that both genetic factors
and intrauterine factors influence the associations be-
tween IBS, anxiety and depression.
The associations between IBS and mental disorders
were demonstrated in the case–control study as well as
in the co-twin analyses, but only among twins with low
birth weight (<2500 g). These findings suggest, for the
first time to our knowledge that restricted fetal growth
seems to be a common contributing factor to the co-
morbidity between IBS, anxiety and depression in the
low range of birth weight. Furthermore, the associations
found in the case–control study did not appear in the
co-twin analyses among twins in normal range of birth
weight (≥2500 g) suggesting that genetic factors in part
could explained the associations between these disor-
ders. Our results might contribute to the understanding
of the underlying mechanisms of IBS and the sub-
classification of IBS.
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